Evidence map›Paper›PMID 31807922›Full record

ReviewVirchows Archiv : an international journal of pathology2020

Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature.

Sarah Péricart, Charlotte Waysse, Aurore Siegfried, Stephanie Struski, Eric Delabesse, Camille Laurent, Solène Evrard

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Nodal T-Cell Lymphoma Transdifferentiated from Mantle Cell Lymphoma with Epstein-Barr Virus Infection.Pathobiology : journal of immunopathology, molecular and cellular biology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sarah PéricartDepartement de Pathologie, Institut Universitaire du Cancer Oncopole, CHU Toulouse, 1 avenue Irène Joliot-Curie, 31059, Toulouse cedex 09, France. pericart.sarah@iuct-oncopole.fr.
Charlotte WaysseDépartement de Chirurgie oncologique, Centre Hospitalier Universitaire - Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse Cedex 9, France.
Aurore SiegfriedDepartement de Pathologie, Institut Universitaire du Cancer Oncopole, CHU Toulouse, 1 avenue Irène Joliot-Curie, 31059, Toulouse cedex 09, France.
Stephanie StruskiLaboratoire de Cytogénétique, Institut Universitaire du Cancer Oncopole de Toulouse, 1 avenue Irène Joliot-Curie, 31059, Toulouse cedex 09, France.
Eric DelabesseLaboratoire Hematologie, Institut Universitaire du Cancer Oncopole de Toulouse, 1 avenue Irène Joliot-Curie, 31059, Toulouse cedex 09, France.
Camille LaurentDepartement de Pathologie, Institut Universitaire du Cancer Oncopole, CHU Toulouse, 1 avenue Irène Joliot-Curie, 31059, Toulouse cedex 09, France.
Solène EvrardDepartement de Pathologie, Institut Universitaire du Cancer Oncopole, CHU Toulouse, 1 avenue Irène Joliot-Curie, 31059, Toulouse cedex 09, France.
Institut universitaire du cancer de Toulouse Oncopole · FRUniversité Toulouse III - Paul Sabatier · FRCentre Hospitalier Universitaire de Toulouse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histiocytic sarcoma (HS) is a rare aggressive hematologic neoplasm that can be associated with low-grade B cell lymphoma. The development of both neoplasms is currently being considered a transdifferentiation mechanism but remains elusive. We report the case of a 65-year-old patient with synchronous development of peritoneal/abdominal HS and grade 1-2 follicular lymphoma (FL). Cytogenetic analysis and targeted next-generation sequencing of both FL and HS tumors identified common genomic alterations such as IGH-BCL2 rearrangement, CREBBP and KMT2D, and aberrations of chromosomes 9q and 19q. However, only the HS tumor had a KRAS mutation while the lymph node involved by FL harbored a TNFAIP3 mutation and both tumors also showed distinct chromosomal alterations. This report strengthens the hypothesis of a common lymphoid progenitor which accumulates genetic alterations leading to two different hematologic malignant diseases with significantly distinct prognoses.

Indexed as

AgedCell TransdifferentiationDNA-Binding ProteinsHistiocytic SarcomaHumansLymph NodesLymphoma, B-CellLymphoma, FollicularMaleNeoplasm ProteinsPrognosisDNA-Binding ProteinsKMT2D protein, humanNeoplasm ProteinsFollicular lymphomaHistiocytic sarcomaTargeted next-generation DNA sequencingTransdifferentiation

Identifiers

PMID31807922
OpenAlexW2992196501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.